Agreement (February 17th, 2015)
This Agreement (the "Agreement"), with an effective date of January 1, 2015, is entered into by Charles River Laboratories, Inc., with its principal place of business at 251 Ballardvale Street, Wilmington, Massachusetts 01887 (the "Company") and Dr. Nancy Gillett, an individual residing at 4520 West Phantom Hill Road, Prescott, AZ 86305 (the "Employee").
Termination Agreement (July 30th, 2010)
TERMINATION AGREEMENT, dated as of July 29, 2010 (this "Agreement"), between WuXi PharmaTech (Cayman) Inc., an exempted company incorporated with limited liability under the laws of the Cayman Islands ("WuXi"), and Charles River Laboratories International, Inc., a Delaware corporation ("Charles River").
AMENDED AND RESTATED DEFERRED COMPENSATION PLAN DOCUMENT February 8, 2006 (Amended December 2, 2008) (February 23rd, 2009)
Charles River Laboratories hereby establishes the Charles River Laboratories Deferred Compensation Plan effective as of January 1, 2006. The Company has established the Plan to attract, retain and motivate certain of its key employees, as well as those of its subsidiaries and affiliates, by providing them with the opportunity to defer receipt of compensation and achieve resulting tax efficiencies. The Plan is intended to be a plan which is unfunded and is maintained by an employer primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employees within the meaning of sections 201(2), 301(a)(3), 401(a)(1) of ERISA and is also intended to be compliant with the requirements of Section 409A of the Code. The Plan shall be administered in a manner consistent with those intents.
CHARLES RIVER LABORATORIES Severance Agreement (February 23rd, 2009)
Agreement (February 23rd, 2009)
This Agreement, dated , 200 (the Effective Date), is made by and between Charles River Laboratories, Inc., a Delaware corporation (the Company) and (the Executive).
STOCK PURCHASE AGREEMENT Dated as of May 9, 2006 Between KENDLE INTERNATIONAL INC. And CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Relating to the Purchase and Sale of the Companies Comprising the Phase II-IV Clinical Services Business (May 10th, 2006)
AGREEMENT (this Agreement) dated as of May 9, 2006 between Kendle International Inc., an Ohio corporation (Buyer), and Charles River Laboratories International, Inc., a Delaware corporation (Seller).
Contract (March 9th, 2005)
Contract (November 1st, 2004)
Exhibit 10.4 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. GRANTED UNDER 2000 INCENTIVE PLAN RESTRICTED STOCK AWARD Unless defined in this Restricted Stock Award (this "AWARD DOCUMENT"), capitalized terms will have the same meanings ascribed to them in the Charles River Laboratories International, Inc. 2000 Incentive Plan (the "PLAN"). Pursuant to Section 4(c) of the Plan, you have been granted restricted shares of Common Stock on the following terms and subject to the provisions of the Plan, which is incorporated by reference. In the event of a conflict between the provisions of the Plan and this Award Document, the provisions of the Plan will prevail. NAME: ((Firstname))((Last_Name)) TOTAL NUMBER OF SHARES GRANTED: ((RS)) Shares FAIR MARKET VALUE PER SHARE: $xx.xx per Share TOTAL FAIR MARKET VALUE OF AWARD: ((Market)) DATE OF GRANT:
SOURCES USES Cash on Hand........................ $ 223.2 Cash Consideration.............. $ 570.4 Revolving Facility*................. 90.3 Refinancings.................... 53.1 Term Facility....................... 350.0 Fees and Expenses............... 40.0 ----------- ---------- $ 663.5 $ 663.5 =========== ========== (August 4th, 2004)